Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: A systematic review and meta-analyses

Journal of Clinical Epidemiology

Volumn 74, Issue , 2016, Pages 57-65

  Hussain, Jamilla A ^a   White, Ian R ^b   Langan, Dean ^c   Johnson, Miriam J ^d   Currow, David C ^a,e   Torgerson, David J ^a   Bland, Martin ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

Differential mortality; Meta analysis; Missing data; Palliative care; Randomized controlled trials; Systematic review

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; DATA ANALYSIS; DEATH; DISEASE COURSE; HUMAN; MISSING DATA; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STATISTICAL SIGNIFICANCE; VALIDITY; MEASUREMENT ACCURACY; META ANALYSIS; PROCEDURES; REPRODUCIBILITY; RISK; STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA;

BIAS (EPIDEMIOLOGY); DATA ACCURACY; DATA INTERPRETATION, STATISTICAL; HUMANS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK;

EID: 84954349466     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2015.12.003     Document Type: Review

References (48)

1. Carpenter J, Bartlett J, Kenward M. http://www.missingdata.org.uk Online: London School of Hygiene and Tropical Medicine. Available at: http://missingdata.lshtm.ac.uk. Accessed December 2, 2014.
2. T.E. Raghunathan What do we do with missing data? Some options for analysis of incomplete data Annu Rev Public Health 25 2004 99 117
3. Panel on Handling Missing Data in Clinical Trials The prevention and treatment of missing data in clinical trials 2010 National Research Council Available at: http://www.cytel.com/hs-fs/hub/1670/file-2411099288-pdf/Pdf/MissingDataNationalAcademyof-Medicine.2010.pdf. Accessed January 8, 2016
4. N.J. Preston, P. Fayers, S.J. Walters, M. Pilling, G.E. Grande, V. Short, and et al. Recommendations for managing missing data, attrition and response shift in palliative and end-of-life care research: part of the MORECare research method guidance on statistical issues Palliat Med 27 2013 899 907
5. D.C. Currow, J.L. Plummer, J.S. Kutner, G.P. Samsa, and A.P. Abernethy Analyzing phase III studies in hospice/palliative care. A solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis J Pain Symptom Manage 44 2012 595 603 English
6. European Medicines Agency. European Medicines Agency guideline on missing data in confirmatory clinical trials. London: 2010 2011. Report No.
7. D. Hui, I. Glitza, G. Chisholm, S. Yennu, and E. Bruera Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials Cancer 119 2013 1098 1105
8. W. Van Mechelen, B. Aertgeerts, K. De Ceulaer, B. Thoonsen, M. Vermandere, F. Warmenhoven, and et al. Defining the palliative care patient: a systematic review Palliat Med 27 2013 197 208
9. C. Lefebvre, E. Manheimer, and J. Glanville Chapter 6: Searching for studies J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions Version 510 [updated March 2011] 2011 Online: The Cochrane Collaboration, England
10. K.F. Schulz, D.G. Altman, D. Moher Group C CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
11. Cochrane Collaboration. Cochrane Pain, Palliative and Supportive Care Group: Cochrane Collaboration Online: Cochrane Collaboration; 2014. Available at: http://papas.cochrane.org. Accessed January 8, 2016.
12. Cochrane PaPaS. Palliative care search strategy Online: Cochrane Collaboration; 2014 [cited 2014]. Available at: http://papas.cochrane.org/papas-trials-register. Accessed January 8, 2016.
13. J.P.T. Higgins, D.G. Altman, and J.A.C. Sterne Chapter 8: Assessing risk of bias in included studies Cochrane handbook for systematic reviews of interventions Version 510 [updated March 2011] [Internet] 2011 Online: The Cochrane Collaboration, England Available at: http://www.cochrane-handbook.org
14. M. Thelwall, and K. Kousha ResearchGate: Disseminating, communicating, and measuring Scholarship? J Assoc Inf Sci Technology 66 2014 876 889
15. M. Borenstein, L.V. Hedges, J.P.T. Higgins, and H.R. Rothstein Chapter 22: Complex data structures. Introduction to meta-analysis 2008 Wiley United Kingdom
16. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
17. J.J. Deeks, J.P.T. Higgins, and D. Altman Chapter 9: Analysing data and undertaking meta-analysis J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions Version 510 [updated March 2011] 2011 Online: The Cochrane Collaboration, England
18. M. Borenstein, L.V. Hedges, J.P.T. Higgins, and H.R. Rothstein Chapter 16: Identifying and quantifying heterogeneity. Introduction to meta-analysis 2008 Wiley United Kingdom
19. J.P. Higgins, and S.G. Thompson Controlling the risk of spurious findings from meta-regression Stat Med 23 2004 1663 1682
20. F. Delphin-Combe, I. Rouch, G. Martin-Gaujard, S. Relland, and P. Krolak-Salmon Effect of a non-pharmacological intervention, Voix d'Or(®), on behavior disturbances in Alzheimer disease and associated disorders Gériatrie Psychol neuropsychiatrie du vieillissement [Internet] 3 2013 323 330
21. B. Hu, T.T. Wang, J. Wu, Z.M. Shi, D.J. Gao, and Y.M. Pan Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial Endoscopy 2 2014 120 126
22. C.Y. Li, S.B. Guo, and N.F. Wang Decompression of acute left-sided malignant colorectal obstruction: comparing transanal drainage tube with metallic stent J Clin Gastroenterol 48 2014 e37 42
23. Y. Chen, X.L. Wang, Z.P. Yan, J.H. Wang, J.M. Cheng, G.Q. Gong, and et al. The use of 25I seed strands for intraluminal brachytherapy of malignant obstructive jaundice Cancer Biother Radiopharm 27 5 2012 317 323
24. M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, E.T. McFadden, and et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
25. C.J. Evans, H. Benalia, N.J. Preston, G. Grande, M. Gysels, V. Short, and et al. The selection and use of outcome measures in palliative and end-of-life care research: the MORECare International Consensus Workshop J Pain Symptom Manage 46 2013 925 937
26. Palliative and end of life care priority setting partnership. Palliative and end of life care priority setting partnership: Putting patients, carers and clinicians at the heart of palliative and end of life care research. Online: 2015. Available at: http://www.palliativecarepsp.org.uk/wp-content/uploads/2015/01/PeolcPSP-Final-Report.pdf. Accessed September 1, 2015.
27. Y. Dong, and C.Y. Peng Principled missing data methods for researchers Springerplus 2 2013 222
28. M. Borenstein, L.V. Hedges, J.P.T. Higgins, and H.R. Rothstein Chapter 17: Prediction intervals. Introduction to meta-analysis 2008 Wiley United Kingdom
29. E.A. Akl, M. Briel, J.J. You, X. Sun, B.C. Johnston, J.W. Busse, and et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review BMJ 344 2012 e2809
30. M. Bell, M. Fiero, N. Horton, and C.-H. Hsu Handling missing data in RCTs; a review of the top medical journals BMC Med Res Methodol 14 2014 118
31. A.M. Wood, I.R. White, and S.G. Thompson Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals Clin Trials 1 2004 368 376
32. R. Crutzen, W. Viechtbauer, D. Kotz, and M. Spigt No differential attrition was found in randomized controlled trials published in general medical journals: a meta-analysis J Clin Epidemiol 66 2013 948 954
33. C. Heneghan, R. Perera, A.A. Ward, D. Fitzmaurice, E. Meats, and P. Glasziou Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes BMC Med Res Methodol 7 2007 18
34. I. Lurie, and S.Z. Levine Meta-analysis of dropout rates in SSRIs versus placebo in randomized clinical trials of PTSD J Nerv Ment Dis 198 2010 116 124
35. R. Crutzen, W. Viechtbauer, M. Spigt, and D. Kotz Differential attrition in health behaviour change trials: a systematic review and meta-analysis Psychol Health 30 2015 122 134
36. J. Rabinowitz, S.Z. Levine, O. Barkai, and O. Davidov Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features Schizophr Bull 35 2009 775 788
37. C.E. Hewitt, B. Kumaravel, J.C. Dumville, and D.J. Torgerson Trial attrition study group. Assessing the impact of attrition in randomized controlled trials J Clin Epidemiol 63 2010 1264 1270
38. L. Ross, B.L. Thomsen, E.H. Boesen, and C. Johansen In a randomized controlled trial, missing data led to biased results regarding anxiety J Clin Epidemiol 57 2004 1131 1137
39. R.M. Sladek, J. Tieman, and D.C. Currow Improving search filter development: a study of palliative care literature BMC Med Inform Decis Mak 7 2007 18
40. O. Barkay, P. Mosler, C.M. Schmitt, G.A. Lehman, J.T. Frakes, J.F. Johanson, and et al. Effect of endoscopic stenting of malignant bile duct obstruction on quality of life J Clin Gastroenterol 47 2013 526 531
41. E. Mok, K.P. Lau, T. Lai, and S. Ching The meaning of life intervention for patients with advanced-stage cancer: development and pilot study Oncol Nurs Forum [Internet] 39 2012 E480 E488
42. M. Baczyk, P. Milecki, M. Pisarek, P. Gut, A. Antczak, and M. Hrab A prospective randomized trial: a comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer (mCRPC) patients with painful bone metastases Neoplasma 2013 328 333
43. H. Zhang, L. Liu, W.Y. Luo, Y.X. Song, and W. She Clinical analysis of vertebral sclerosis angioplasty and resection for the treatment of spinal metastases [Chinese] Chin J Cancer Prev Treat 20 5 2013 374 376
44. J.A.C. Sterne, M. Egger, and D. Moher Chapter 10: Addressing reporting biases. Cochrane handbook for systematic reviews of interventions Version 510 [updated March 2011] [Internet] 2011 Online: The Cochrane Collaboration, England Available at: http://www.cochrane-handbook.org. Accessed January 8, 2016
45. B.F. Kurland, L.L. Johnson, B.L. Egleston, and P.H. Diehr Longitudinal data with follow-up truncated by death: match the analysis method to research aims Stat Sci 24 2009 211
46. D.B. Rubin Causal inference through potential outcomes and principal stratification: application to studies with "censoring" due to death Stat Sci 21 2006 299 309
47. T. Li, S. Hutfless, D.O. Scharfstein, M.J. Daniels, J.W. Hogan, R.J. Little, and et al. Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus J Clin Epidemiol 67 2014 15 32
48. S. Treweek, D.G. Altman, P. Bower, M. Campbell, I. Chalmers, S. Cotton, and et al. Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform Trials 16 2015 261